Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

Richtlijn: Erfelijke darmkanker (1.0)253 - van Oostrom Ivan Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RHet al. Experience of parental cancer in childhood is a risk factor for psychological distress during geneticcancer susceptibility testing. Ann Oncol 2006;17:1090-5.254 - van Oostrom Ivan Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RHet al. Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC geneticsusceptibility testing. Eur J Cancer 2007;43:71-7.255 - Petersen GMPetersen GM. Genetic testing and counselling in familial adenomatous polyposis. Oncology1996;10:89-94.256 - Peterson SKPeterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK et al. How familiescommunicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet2003;119C:78-86.257 - Phillips RKPhillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP et al. A randomized, double blind,placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis infamilial adenomatous polyposis. Gut 2002;50:857-60.258 - Pieterse AHPieterse AH , Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counselingconsultation: change in counselees' cognitions and anxiety, and association with addressing their needsand preferences. Am J Med Genet A. 2005;137:27-35.259 - Pieterse AHPieterse AH, Van Dulmen AM, Ausems MG, Beemer FA, Bensing JM. Communication in cancer geneticcounselling: does it reflect counselees' previsit needs and preferences? Br J Cancer 2005;92:1671-8.260 - Pieterse AHPieterse AH, Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counselingconsultation: change in counselees' cognitions and anxiety, and association with addressing their needsand preferences. Am J Med Genet 2005;A 137:27-35.261 - Piñol VPiñol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X et al. Gastrointestinal Oncology Group ofthe Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatelliteinstability, and immunohistochemistry for the identification of patients with hereditary nonpolyposiscolorectal cancer. JAMA 2005;293:1986-94.262 - Plaschke JPlaschke J, Engel C, Kruger S, Holinski-Feder E, Pagenstecher C, Mangold E et al. Lower incidence ofcolorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutationscompared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis ColorectalCancer Consortium. J Clin Oncol 2004;22:4486-94.263 - The Polyposis RegistryThe Polyposis Registry. London, UK. Protocol for the management of patients with polyposis. A guide formedical staff, 2006.03/11/08 Erfelijke darmkanker (1.0) 106